Stolen devices that failed quality control were sold to the public: FDA

The FDA reports that a medical company, Dexcom, discovered two lots of its Dexcom G7 continuous glucose monitoring devices were stolen by a third party and sold to the public after being intended for scrapping due to failed quality control.